Pharmabiz7h
AGI Greenpac expands global pharmaceutical packaging footprint with new Dubai office
AGI Greenpac expands global pharmaceutical packaging footprint with new Dubai office: Our Bureau, Mumbai Thursday, December ...
Pharmabiz7h
Zeno Health launches 181st medical store, expands its product portfolio
Zeno Health launches 181st medical store, expands its product portfolio: Our Bureau, Mumbai Thursday, December 12, 2024, ...
Pharmabiz56m
FIP releases new skills reference guide focuses on pharmacists supporting self-care for Universal Health Coverage Day
International Pharmaceutical Federation (FIP) has published a ‘Knowledge and skills reference guide for pharmacists supporting self-care’ on Universal Health Coverage Day observed annually on December ...
Pharmabiz36m
Cipher Pharma announces Moberg Pharma’s nail fungus treating product MOB-015 fails to meet primary endpoint in phase 3 study
Cipher Pharmaceuticals Inc, a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products, has announced that its partner, Moberg Pharma AB, ...
Pharmabiz2h
Spruce Biosciences announces topline results from CAHmelia-204, CAHptain-205 in adult and paediatric congenital adrenal hyperplasia
Spruce Biosciences, Inc, a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological and endocrine disorders with significant unmet medical need, ...
Pharmabiz5h
Over 1 in 5 adults worldwide has a genital herpes infection – WHO
Around 846 million people aged between 15 and 49 are living with genital herpes infections – more than 1 in 5 of this age-group globally – according to new estimates released. At least 1 person each ...
Pharmabiz6h
MannKind and Cipla announce CDSCO approves Afrezza inhalation powder in India
MannKind and Cipla announce CDSCO approves Afrezza inhalation powder in India: Our Bureau, Mumbai Thursday, December 12, 2024, 17:30 Hrs [IST] MannKind Corporation, a company focu ...
Pharmabiz7h
Akoya Biosciences, NeraCare ink license agreement to develop & commercialize Immunoprint test for early-stage melanoma
Akoya Biosciences, NeraCare ink license agreement to develop & commercialize Immunoprint test for early-stage melanoma: Marlborough, Massachusetts Thursday, December 12, 2024, 17: ...
Pharmabiz10h
UK MHRA grants marketing authorization to Leo Pharma’s delgocitinib to treat adult patients with moderate to severe chronic hand eczema
UK MHRA grants marketing authorization to Leo Pharma’s delgocitinib to treat adult patients with moderate to severe chronic hand eczema: United Kingdom Thursday, December 12, 20 ...
Pharmabiz10h
Orbis India sees bright future begins with clear vision calls for early eye care in children
Orbis India sees bright future begins with clear vision calls for early eye care in children: Our Bureau, Bengaluru Thursday, December 12, 2024, 13:50 Hrs [IST] Orbis India, a non ...
Pharmabiz14h
US FDA grants fast track designation to two Sanofi’s combination vaccine candidates to prevent influenza & Covid-19 infections
US FDA grants fast track designation to two Sanofi’s combination vaccine candidates to prevent influenza & Covid-19 infections: Paris Thursday, December 12, 2024, 10:00 Hrs [IST ...
Pharmabiz15h
Arvinas, Pfizer announce initial phase 1b data from the TACTIVE-U sub-study of vepdegestrant in combo with abemaciclib at 2024 SABC symposium
Arvinas, Pfizer announce initial phase 1b data from the TACTIVE-U sub-study of vepdegestrant in combo with abemaciclib at 2024 SABC symposium: New Haven, Connecticut Thursday, Dec ...